Your browser doesn't support javascript.
loading
Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial.
Fehlings, M G; Nakashima, H; Nagoshi, N; Chow, D S L; Grossman, R G; Kopjar, B.
Afiliação
  • Fehlings MG; Division of Neurosurgery and Spinal Program, Department of Surgery, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada.
  • Nakashima H; Division of Neurosurgery and Spinal Program, Department of Surgery, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada.
  • Nagoshi N; Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Chow DS; Division of Neurosurgery and Spinal Program, Department of Surgery, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada.
  • Grossman RG; Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.
  • Kopjar B; Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX, USA.
Spinal Cord ; 54(1): 8-15, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26099215
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Traumatismos da Medula Espinal / Fármacos Neuroprotetores / Riluzol Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Traumatismos da Medula Espinal / Fármacos Neuroprotetores / Riluzol Idioma: En Ano de publicação: 2016 Tipo de documento: Article